ISIN | CH0467052848 |
---|---|
Valor Number | 46705284 |
Bloomberg Global ID | AXASWES SW |
Fund Name | AXA (CH) Strategy Fund - Swiss Equity CHF S Distribution Yearly CHF |
Fund Provider |
Axa Leben AG
Phone: +41 0800 809 809 Web: https://www.axa-winterthur.ch |
Fund Provider | Axa Leben AG |
Representative in Switzerland | |
Distributor(s) |
AXA Investment Managers Schweiz AG Zürich Phone: +41 43 299 12 12 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The investment objective of this subfund is to generate growth in value and an appropriate return in CHF from an actively managed portfolio of Swiss equities. The fund management company strives to achieve an equity market exposure of at least 90% in the Swiss Equity CHF. |
Peculiarities |
Current Price * | 134.17 CHF | 31.10.2024 |
---|---|---|
Previous Price * | 136.15 CHF | 30.10.2024 |
52 Week High * | 139.97 CHF | 30.08.2024 |
52 Week Low * | 116.98 CHF | 02.11.2023 |
NAV * | 134.17 CHF | 31.10.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 226,813,206 | |
Unit/Share Assets *** | 226,813,206 | |
Trading Information SIX |
YTD Performance | +8.54% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
---|---|---|
1 month | -3.47% |
30.09.2024 - 31.10.2024
30.09.2024 31.10.2024 |
3 months | -3.66% |
31.07.2024 - 31.10.2024
31.07.2024 31.10.2024 |
6 months | +3.04% |
30.04.2024 - 31.10.2024
30.04.2024 31.10.2024 |
1 year | +16.93% |
31.10.2023 - 31.10.2024
31.10.2023 31.10.2024 |
2 years | +16.80% |
31.10.2022 - 31.10.2024
31.10.2022 31.10.2024 |
3 years | -3.22% |
02.11.2021 - 31.10.2024
02.11.2021 31.10.2024 |
5 years | +34.23% |
31.10.2019 - 31.10.2024
31.10.2019 31.10.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 6.91% | |
---|---|---|
Nestle SA | 6.41% | |
Novartis AG Registered Shares | 4.31% | |
Julius Baer Gruppe AG | 4.23% | |
Lonza Group Ltd | 3.87% | |
Chocoladefabriken Lindt & Spruengli AG | 3.40% | |
VAT Group AG | 3.34% | |
Georg Fischer AG | 3.16% | |
Compagnie Financiere Richemont SA Class A | 3.10% | |
Sandoz Group AG Registered Shares | 3.08% | |
Last data update | 30.09.2024 |
TER | 0.40% |
---|---|
TER date | 31.03.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.70% |
Ongoing Charges *** | 0.45% |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |